[Skip to Content]
[Skip to Content Landing]
October 25, 1995

New Initiative for Global TB Control

JAMA. 1995;274(16):1255-1257. doi:10.1001/jama.1995.03530160007002

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


AN INTERNATIONAL group of experts has developed a set of recommendations for the global control of tuberculosis (TB), while lashing out at governments and pharmaceutical companies for ignoring the world's top infectious disease killer.

Their strategy reiterates the importance of completed chemotherapy as a means to cure TB and prevent its spread. The broad-based recommendations note the promise of molecular techniques in new drug and vaccine development, as well as the roles that patient and physician behavior play in controlling the disease.

But TB also is a highly political disease, experts stressed during a 2-day conference in Washington, DC, where they finalized the recommendations. London, England—based medical journal The Lancet sponsored the meeting and published the recommendations in its September 23 issue.

The politics of TB have been evident in the United States for more than two decades, said Lee B. Reichman, MD, MPH, executive director of the New Jersey

First Page Preview View Large
First page PDF preview
First page PDF preview